133 related articles for article (PubMed ID: 38885752)
1. Predictors of pocket hematoma formation after cardiac implantable electronic device procedure and the role of subcutaneous heparin.
Peters GW; Patel HP; France J; Mazimba S; Deshmukh A; Dani SS; Haines DE; Mehta NK
Heart Rhythm; 2024 Jun; ():. PubMed ID: 38885752
[No Abstract] [Full Text] [Related]
2. Clinical predictors of pocket hematoma after cardiac device implantation and replacement.
Ferretto S; Mattesi G; Migliore F; Susana A; De Lazzari M; Iliceto S; Leoni L; Bertaglia E
J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):123-127. PubMed ID: 31789710
[TBL] [Abstract][Full Text] [Related]
3. Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: A meta-analysis.
Kewcharoen J; Kanitsoraphan C; Thangjui S; Leesutipornchai T; Saowapa S; Pokawattana A; Navaravong L
J Arrhythm; 2021 Jun; 37(3):635-644. PubMed ID: 34141016
[TBL] [Abstract][Full Text] [Related]
4. Predictors of pocket hematoma after cardiac implantable electronic device surgery: A nationwide cohort study.
Fensman SK; Grove EL; Johansen JB; Jørgensen OD; Frausing MHJP; Kirkfeldt RE; Nielsen JC
J Arrhythm; 2022 Oct; 38(5):748-755. PubMed ID: 36237873
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
Chen HC; Chen YL; Guo BF; Tsai TH; Chang JP; Pan KL; Lin YS; Chen MC
Can J Cardiol; 2013 Sep; 29(9):1110-7. PubMed ID: 23474139
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Implantable Electronic Device Surgery Following Left Ventricular Assist Device Implantation.
Black-Maier E; Lewis RK; Loungani R; Rehorn M; Friedman DJ; Bishawi M; Schroder JN; Milano CA; Katz JN; Patel CB; Rogers JG; Hegland DD; Jackson KP; Frazier-Mills C; Pokorney SD; Daubert JP; Piccini JP
JACC Clin Electrophysiol; 2020 Sep; 6(9):1131-1139. PubMed ID: 32972548
[TBL] [Abstract][Full Text] [Related]
7. Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.
Demir GG; Guler GB; Guler E; Güneş H; Kizilirmak F; Karaca İO; Omaygenç MO; Çakal B; Olgun E; Savur U; Ibisoglu E; Barutçu I; Kiliçaslan F
Acta Cardiol; 2017 Feb; 72(1):47-52. PubMed ID: 28597740
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review of Short-Term Outcomes of Leadless Pacemaker Implantation After Transvenous Lead Removal of Infected Cardiac Implantable Electronic Device.
Tan MC; Tan JL; Tay ST; Sorajja D; Scott L; Cha YM; Russo AM; Hussein A; Lee JZ
Am J Cardiol; 2023 Sep; 203():444-450. PubMed ID: 37542954
[TBL] [Abstract][Full Text] [Related]
9. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Novel Pocket Compression Device on Hematomas Following Cardiac Electronic Device Implantation in Patients Receiving Direct Oral Anticoagulants.
Fei YP; Wang L; Zhu CY; Sun JC; Hu HL; Zhai CL; He CJ
Front Cardiovasc Med; 2022; 9():817453. PubMed ID: 35282349
[TBL] [Abstract][Full Text] [Related]
11. Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?
Beton O; Saricam E; Kaya H; Yucel H; Dogdu O; Turgut OO; Berkan O; Tandogan I; Yilmaz MB
BMC Cardiovasc Disord; 2016 Apr; 16():73. PubMed ID: 27105588
[TBL] [Abstract][Full Text] [Related]
12. Local gentamicin-collagen sponge reduces cardiovascular implantable electronic device infections and pocket hematoma.
Monaco C; Barone L; Cammalleri V; Stifano G; Magliano G; Geuna F; Romeo F; Sergi D
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5218-5224. PubMed ID: 35916820
[TBL] [Abstract][Full Text] [Related]
13. Impact on All-Cause and Cardiovascular Mortality of Cardiac Implantable Electronic Device Complications: Results From the POINTED Registry.
Palmisano P; Guerra F; Dell'Era G; Ammendola E; Ziacchi M; Laffi M; Troiano F; Prenna E; Russo V; Angeletti A; Guido A; Occhetta E; Nigro G; Biffi M; Gaggioli G; Capucci A; Accogli M;
JACC Clin Electrophysiol; 2020 Apr; 6(4):382-392. PubMed ID: 32327071
[TBL] [Abstract][Full Text] [Related]
14. Device implantation for patients on antiplatelets and anticoagulants: Use of suction drain.
Mukherjee SS; Saggu D; Chennapragada S; Yalagudri S; Nair SG; CalamburNarasimhan
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S389-S393. PubMed ID: 30595295
[TBL] [Abstract][Full Text] [Related]
15. Use of MPH hemostatic powder for electrophysiology device implantation reduces postoperative rates of pocket hematoma and infection.
Reynbakh O; Akhrass P; Souvaliotis N; Pamidimukala CK; Nahar H; Bastawrose J; Boktor P; Aziz JE; Mehta D; Aziz EF
Curr Med Res Opin; 2018 Oct; 34(10):1861-1867. PubMed ID: 29764229
[TBL] [Abstract][Full Text] [Related]
16. Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention.
Spinoni EG; Ghiglieno C; Costantino S; Battistini E; Dell'Era G; Porcellini S; Santagostino M; De Vecchi F; Renda G; Patti G
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207259
[TBL] [Abstract][Full Text] [Related]
17. Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT).
Aydin A; Golian M; Klein A; Redpath C; Davis DR; Ramirez DF; Nair GM; Green M; Sadek M; Nery PB; Hansom SP; Corrales-Medina V; Wells GA; Birnie DH
Heliyon; 2023 Dec; 9(12):e22229. PubMed ID: 38046145
[TBL] [Abstract][Full Text] [Related]
18. Pocket related complications following cardiac electronic device implantation in patients receiving anticoagulation and/or dual antiplatelet therapy: prospective evaluation of different preventive strategies.
Awada H; Geller JC; Brunelli M; Ohlow MA
J Interv Card Electrophysiol; 2019 Apr; 54(3):247-255. PubMed ID: 30460588
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
Alshoubaki O; Al Darabaa Z; Odat O; Qubbaj A; Alhyari R; Alshare S; Ghanma I
Med Arch; 2021 Feb; 75(1):56-60. PubMed ID: 34012201
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future.
Xiang K; Catanzaro JN; Elayi C; Esquer Garrigos Z; Sohail MR
Cureus; 2021 Feb; 13(2):e13088. PubMed ID: 33728111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
